Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk
NCT03000335
·
clinicaltrials.gov ↗
UNKNOWN
Status
65
Enrollment
INDUSTRY
Sponsor class
Conditions
B-cell Acute Lymphoblastic Leukemia
Sponsor
Curewize Health Ltd.